Navigation Links
Genmab Announces 2008 First Half Year Results
Date:8/27/2008

Summary: Genmab Reports Results for the Six Month Period Ended June 30,

2008

COPENHAGEN, August 27 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today results for the six month period ended June 30, 2008. During this period, Genmab reported the following results:

Genmab's revenues were DKK 277 million (USD 59 million) for the first half of 2008. In the same period of 2007, Genmab recognized revenues of DKK 280 million (USD 59 million).

An operating loss of DKK 471 million (USD 100 million). This compares to an operating loss of DKK 119 million (USD 25 million) reported for the corresponding period of 2007. The larger operating loss was driven by the increased level of pre-clinical and clinical activities associated with the advancement of our product pipeline.

Net financial income for the first half of 2008 reflected a net loss of DKK 20 million (USD 4 million), compared to a net income of DKK 32 million (USD 7 million) in the same period of 2007. The net financial income reflects a combination of interest income and fair market value adjustments from our portfolios of marketable securities and unrealized foreign exchange losses derived from the continued weakening of the USD against the DKK in the first half of 2008.

A net loss of DKK 491 million (USD 104 million) compared to a net loss of DKK 87 million (USD 18 million) for the same period in 2007. The net loss per share was DKK 11.02 (USD 2.33) for the first half of 2008 compared to DKK 2.01 (USD 0.42) in the first half of 2007.

Genmab ended the six month period with cash and marketable securities of DKK 2.1 billion (USD 443 million), which is a decrease of DKK 1.6 billion (USD 338 million) from the end of 2007. The decrease primarily arises from the DKK 1.2 billion (USD 240 million at the date of acquisition) acquisition of the manufacturing facility in March 2008.

Highlights

During the second quarter o
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
2. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 Los Lunas, N.M., resident Lyndsi ... until last year, when she attended a pageant and ... (PH) – a debilitating disease of the lungs that ... to right-heart failure. The disease turned the Alderete’s world ... entered the pageant to raise awareness about her daughter’s ...
(Date:3/26/2015)... LinkToBanking, a Preferred Partner Network ... Fleming as Chairman of the Board and Robert ... With their combined knowledge and experience in ... Fleming and Mr. Casares will provide exceptional guidance ... related businesses. , About Tom Fleming, Mr. Fleming, ...
(Date:3/26/2015)... 2015 The Van Nuys dentists ... they are offering a new patient special to welcome new ... among the best ways to protect dental health, but patients ... more likely to delay or avoid these checkups. This special ... need at an affordable price. The dentists at Hamlin Dental ...
(Date:3/26/2015)... WA (PRWEB) March 26, 2015 Dr. Bryan ... to announce his new March special. With spring ... of his Bellevue patients, he wants them to look and ... 20% off ZO Skincare products and any facial treatments when ... , To claim the deal and start getting radiant and ...
(Date:3/26/2015)... Utah (PRWEB) March 26, 2015 With more ... revenue days, doTERRA is dominating the essential oils industry. And ... they are building strong roots at home in Utah County. ... Valley Business of the Year by the Utah Valley ... the Mayor’s award and has now been awarded ...
Breaking Medicine News(10 mins):Health News:Albuquerque Area Mom Enters Mrs. New Mexico Pageant to Help Fight Pulmonary Hypertension 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 3Health News:Hamlin Dental Group is Now Accepting New Patients and Offering a New Patient Special 2Health News:Dr. Bryan McIntosh Offers March Special on ZO Skincare and Facial Services 2Health News:doTERRA Named Utah Valley Business of the Year by BusinessQ 2Health News:doTERRA Named Utah Valley Business of the Year by BusinessQ 3
... lung cancer afflicts some smokers and not others, according to ... Annual Meeting 2009. , "A history of smoking has always ... it is actually not very accurate," said Jian-Min Yuan, Ph.D., ... Minnesota. "Smoking absolutely increases your risk, but why it does ...
... Those with higher levels of a compound had nearly 9 ... News) -- Someday, a simple urine test might spot ... The research is still in its preliminary stages, and it ... But if it works, the urine-based screen could give added ...
... of the Neuroscience Center of Excellence, Boyd Professor, and ... Degenerative Diseases Research at LSU Health Sciences Center New ... omega three fatty acid in the diet protects brain ... from a gene mutation in neurodegenerative diseases like Parkinson,s ...
... recently released study led by Joseph A. Roscoe, Ph.D. ... American Cancer Society and the National Cancer Society concludes ... associated with radiation-therapy used to treat cancer patients. ... P6 acupressure point on each wrist. This all ...
... travelers and shift workers, study suggests , , FRIDAY, April ... caused by disruption of internal clocks in two neural ... treatments, say U.S. researchers. , The University of Washington ... but linked, groups of neurons in a brain structure ...
... Dow Jones VentureSource: Investment at Lowest Level Since 1998, ... Concentrating on Established Companies SAN FRANCISCO and NEW ... VentureSource shows that the U.S. venture capital industry continued ... Venture capitalists invested just $3.90 billion in U.S. companies ...
Cached Medicine News:Health News:Urine test may determine if a smoker is at risk for lung cancer 2Health News:Urine Test Could Gauge Smokers' Lung Cancer Risk 2Health News:LSUHSC research shows fish oil protects against diseases like Parkinson's 2Health News:Relief Is Available for Cancer Patients Suffering from Radiation Therapy-Related Nausea 2Health News:Jet Lag Upsets Brain's Internal Clocks 2Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 2Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 3Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 4Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 5
(Date:3/26/2015)... , March 26, 2015  The new Phonak CROS ... the unaidable ear to a Venture hearing aid worn on ... to hear speech from the side they could not hear ... is as easy and intuitive as a normal binaural fit, ... solution during the fitting session.    "Fitting single-sided ...
(Date:3/26/2015)... ATHENS, Ohio , March 26, 2015  An Ohio ... over their own medical records.  As CEO for a start-up ... Reid is launching a new business that will empower ... a quantum leap over today,s insecure methods. ... Secure Exchange of Encrypted Data – will enable people to ...
(Date:3/26/2015)... , March 26, 2015  CNBC profiled MJ Freeway ... part of a series "How I Did It," which features ... the High Road" released yesterday, illustrates how two tech ... leading IT providers to the marijuana industry. ... describes how Co-Founders Amy Poinsett and Jessica Billingsley ...
Breaking Medicine Technology:Phonak CROS II: The smart solution for single-sided deafness 2Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 2Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 3Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 4MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It" 2
... 3, 2011 NxStage® Medical, Inc. (Nasdaq: ... today reported record financial results for the second quarter ... well above the top end of its guidance range. ... the second quarter of 2011 increased to $53.8 million, ...
... Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), ... that the United States Patent and Trademark Office has ... patent application directed to the fundamental technology involved in ... delivery systems. The allowable subject matter is directed to ...
Cached Medicine Technology:NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 2NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 3NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 4NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 5NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 6NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 7NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 8Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 2Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 3Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: